Works matching IS 10092137 AND DT 2022 AND VI 30 AND IP 2


Results: 56
    1
    2
    3
    4
    5
    6

    滤泡淋巴瘤免疫靶向治疗研究进展.

    Published in:
    Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 2, p. 627, doi. 10.19746/j.cnki.issn1009-2137.2022.02.051
    By:
    • 邱立华;
    • 郑雅心;
    • 张志蓉;
    • 田晨
    Publication type:
    Article
    7

    ABO血型基因分型方法的进展与应用.

    Published in:
    Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 2, p. 622, doi. 10.19746/j.cnki.issn1009-2137.2022.02.050
    By:
    • 李慧;
    • 冯晨晨;
    • 陈青
    Publication type:
    Article
    8
    9
    10

    NMT3a在氢醌致造血干细胞毒性中的作用研究.

    Published in:
    Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 2, p. 607, doi. 10.19746/j.cnki.issn1009-2137.2022.02.047
    By:
    • 武坤;
    • 聂波;
    • 杨金荣;
    • 贺振新;
    • 程沈菊;
    • 李艳红;
    • 晋臻;
    • 史明霞
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    多发性骨髓瘤患者血清补体C1q 的变化.

    Published in:
    Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 2, p. 506, doi. 10.19746/j.cnki.issn1009-2137.2022.02.030
    By:
    • 桂成思;
    • 刘尚勤
    Publication type:
    Article
    28

    全身DWI在多发性骨髓瘤骨病评估中的作用.

    Published in:
    Journal of Experimental Hematology / Zhongguo Shiyan Xueyexue Zazhi, 2022, v. 30, n. 2, p. 501, doi. 10.19746/j.cnki.issn1009-2137.2022.02.029
    By:
    • 谢妍;
    • 惠友友;
    • 姚飞荣;
    • 胡春洪;
    • 颜灵芝;
    • 吴德沛;
    • 傅琤琤
    Publication type:
    Article
    29
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50